Skip Nav Destination
Issues
Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.
Diabetes February 1999, Vol.48, 241-253. doi:https://doi.org/10.2337/diabetes.48.2.241
Renal glucose production during insulin-induced hypoglycemia in humans.
Diabetes February 1999, Vol.48, 261-266. doi:https://doi.org/10.2337/diabetes.48.2.261
Altered energy balance causes selective changes in melanocortin-4(MC4-R), but not melanocortin-3 (MC3-R), receptors in specific hypothalamic regions: further evidence that activation of MC4-R is a physiological inhibitor of feeding.
Diabetes February 1999, Vol.48, 267-271. doi:https://doi.org/10.2337/diabetes.48.2.267
Regulation of ob gene expression and leptin secretion by insulin and dexamethasone in rat adipocytes.
Diabetes February 1999, Vol.48, 272-278. doi:https://doi.org/10.2337/diabetes.48.2.272
Functional properties of leptin receptor isoforms: internalization and degradation of leptin and ligand-induced receptor downregulation.
Diabetes February 1999, Vol.48, 279-286. doi:https://doi.org/10.2337/diabetes.48.2.279
Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats.
Diabetes February 1999, Vol.48, 287-291. doi:https://doi.org/10.2337/diabetes.48.2.287
Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting.
Diabetes February 1999, Vol.48, 292-298. doi:https://doi.org/10.2337/diabetes.48.2.292
Cellular immune responses against proinsulin: no evidence for enhanced reactivity in individuals with IDDM.
Diabetes February 1999, Vol.48, 299-303. doi:https://doi.org/10.2337/diabetes.48.2.299
Genes expressed during the differentiation of pancreatic AR42J cells into insulin-secreting cells.
Diabetes February 1999, Vol.48, 304-309. doi:https://doi.org/10.2337/diabetes.48.2.304
Phosphorylated insulin-like growth factor binding protein 1 is increased in pregnant diabetic subjects.
Diabetes February 1999, Vol.48, 321-326. doi:https://doi.org/10.2337/diabetes.48.2.321
High-fat meals reduce 24-h circulating leptin concentrations in women.
Diabetes February 1999, Vol.48, 334-341. doi:https://doi.org/10.2337/diabetes.48.2.334
Hepatic glucose cycling does not contribute to the development of hyperglycemia in Zucker diabetic fatty rats.
Diabetes February 1999, Vol.48, 342-346. doi:https://doi.org/10.2337/diabetes.48.2.342
Plasma leptin and insulin levels in weight-reduced obese women with normal body mass index: relationships with body composition and insulin.
Diabetes February 1999, Vol.48, 347-352. doi:https://doi.org/10.2337/diabetes.48.2.347
An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats.
Diabetes February 1999, Vol.48, 353-357. doi:https://doi.org/10.2337/diabetes.48.2.353
Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans.
Diabetes February 1999, Vol.48, 358-364. doi:https://doi.org/10.2337/diabetes.48.2.358
Induction of obesity and hyperleptinemia by central glucocorticoid infusion in the rat.
Diabetes February 1999, Vol.48, 365-370. doi:https://doi.org/10.2337/diabetes.48.2.365
Hyperglycemia-induced embryonic dysmorphogenesis correlates with genomic DNA mutation frequency in vitro and in vivo.
Diabetes February 1999, Vol.48, 371-376. doi:https://doi.org/10.2337/diabetes.48.2.371
Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
Diabetes February 1999, Vol.48, 383-390. doi:https://doi.org/10.2337/diabetes.48.2.383
Effect of acute ketosis on the endothelial function of type 1 diabetic patients: the role of nitric oxide.
A Avogaro; L Calò; F Piarulli; M Miola; S deKreutzenberg; A Maran; A Burlina; R Mingardi; A Tiengo; S Del Prato
Diabetes February 1999, Vol.48, 391-397. doi:https://doi.org/10.2337/diabetes.48.2.391
A sib-pair analysis study of 15 candidate genes in French families with morbid obesity: indication for linkage with islet 1 locus on chromosome 5q.
K Clément; C Dina; A Basdevant; N Chastang; V Pelloux; N Lahlou; M Berlan; D Langin; B Guy-Grand; P Froguel
Diabetes February 1999, Vol.48, 398-402. doi:https://doi.org/10.2337/diabetes.48.2.398
Mutational analysis of the coding regions of the genes encoding protein kinase B-alpha and -beta, phosphoinositide-dependent protein kinase-1, phosphatase targeting to glycogen, protein phosphatase inhibitor-1, and glycogenin: lessons from a search for genetic variability of the insulin-stimulated glycogen synthesis pathway of skeletal muscle in NIDDM patients.
L Hansen; H Fjordvang; S K Rasmussen; H Vestergaard; S M Echwald; T Hansen; D Alessi; S Shenolikar; A R Saltiel; F Barbetti; O Pedersen
Diabetes February 1999, Vol.48, 403-407. doi:https://doi.org/10.2337/diabetes.48.2.403
A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland.
T Otonkoski; C Ammälä; H Huopio; G J Cote; J Chapman; K Cosgrove; R Ashfield; E Huang; J Komulainen; F M Ashcroft; M J Dunne; J Kere; P M Thomas
Diabetes February 1999, Vol.48, 408-415. doi:https://doi.org/10.2337/diabetes.48.2.408
Association of polymorphism in the NeuroD/BETA2 gene with type 1 diabetes in the Japanese.
I Iwata; S Nagafuchi; H Nakashima; S Kondo; T Koga; Y Yokogawa; T Akashi; T Shibuya; Y Umeno; T Okeda; S Shibata; S Kono; M Yasunami; H Ohkubo; Y Niho
Diabetes February 1999, Vol.48, 416-419. doi:https://doi.org/10.2337/diabetes.48.2.416
Diabetic nephropathy is not associated with the dinucleotide repeat polymorphism upstream of the aldose reductase (ALR2) gene but with erythrocyte aldose reductase content in Japanese subjects with type 2 diabetes.
S Maeda; M Haneda; H Yasuda; T Tachikawa; K Isshiki; D Koya; M Terada; H Hidaka; A Kashiwagi; R Kikkawa
Diabetes February 1999, Vol.48, 420-422. doi:https://doi.org/10.2337/diabetes.48.2.420
Mutation in the HNF-4alpha gene affects insulin secretion and triglyceride metabolism.
Diabetes February 1999, Vol.48, 423-425. doi:https://doi.org/10.2337/diabetes.48.2.423
Leptin promotes aggregation of human platelets via the long form of its receptor.
Diabetes February 1999, Vol.48, 426-429. doi:https://doi.org/10.2337/diabetes.48.2.426
Streptozotocin treatment upregulates uncoupling protein 3 expression in the rat heart.
Diabetes February 1999, Vol.48, 430-435. doi:https://doi.org/10.2337/diabetes.48.2.430